UK 5 Year Antimicrobial Resistance (AMR) Strategy 2013–2018: Annual progress report and implementation plan 2014

The UK government has published the first progress report on its UK five year AMR Strategy that was published in November 2013, identifying seven key areas for action to reduce and contain the spread of antimicrobial resistance.  This progress report – UK 5 Year Antimicrobial Resistance (AMR) Strategy 2013–2018: Annual progress report and implementation plan 2014 –  summarises progress in the seven areas across human and animal health in the first year of the strategy.

The British Society for Antimicrobial Chemotherapy welcomes publication of the report and is especially pleased to note inclusion of a a detailed implementation plan which highlights actions projected to have the biggest impact in slowing the spread of AMR.   The report highlights the importance of infection prevention and control (IPC) practices and antimicrobial stewardship  which are viewed as key at all levels and across all sectors, alongside ensuring a sustainable supply of suitable new diagnostics and treatments.  The report also includes reference to the central importance of comprehensive data collection systems, professional leadership and public awareness, acknowledging AMR is a global concern and the UK cannot address it alone.

As a Society BSAC is working hard to support implementation of the UK and WHO AMR strategies and is pleased to be able to offer a range of initiatives that will potentially make significant and sustained contributions to fulfilment of both.  In addition to long standing programmes for susceptibility testing and resistance surveillance, the Society is: